Metabolic Mapping of Breast Cancer with Multiphoton Spectral and Lifetime Imaging
Abstract
Currently we designed and implemented a combined spectral and lifetime imaging system which combines the benefits of multiphoton microscopy, spectral discrimination, lifetime analysis and temporal information. This system has efficiencies of > 50% and capability to collect broad spectrums (from 380nm-700nm). We determined the fluorescence source under our imaging condition is from NADH by this combined spectral and lifetime imaging system. Furthermore, we validated the accuracy of our lifetime analysis method. Our preliminary results of metabolic mapping in different human breast cell lines via fluorescence lifetime measurement of Co-Enzyme NADH showed very interesting results in differences of the lifetime and contribution of bound NADH between human normal breast cell line (MCF10a) and human breast cancer cell lines (T47D and MBA_MD_231). A 2-Deoxy-D-glucose (2DG) perturbation study is underway to link these finds with glycolysis.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 01, 2007
- Accession Number
- ADA469761
Entities
People
- Long Yan
Organizations
- University of Wisconsin–Madison